Content Details
Written By
MMST, MBBS
Reviewed By
MD (Pharma), MBBS
Last updated on:
22 Mar 2019 | 01:42 PM (IST)
Want to know more?
Read Our Editorial Policy

Torsirin 100 mg/5ml Injection


Overview

Uses of Torsirin Injection

Torsirin 100 mg/5ml Injection is used in the treatment of cancer of colon and rectum.

Torsirin Injection side effects

Common
  • Fatigue
  • Nausea
  • Vomiting
  • Weakness
  • Hair loss
  • Fever
  • Anemia (low number of red blood cells)
  • Diarrhea
  • Decreased white blood cell count (neutrophils)
  • Decreased appetite
  • Mucosal inflammation

How to use Torsirin Injection

Your doctor or nurse will give you this medicine. Kindly do not self administer.

How Torsirin Injection works

Torsirin 100 mg/5ml Injection is an anti-cancer medication. It works by suppressing the activity of an enzyme (topoisomerase I) involved in DNA multiplication of the cancer cells. This slows the growth of cancer cells and eventually kills them.

Torsirin Injection related warnings

Alcohol
Interaction with alcohol is unknown. Please consult your doctor.
Pregnancy
WEIGH RISKS VS BENEFITS
Torsirin 100 mg/5ml Injection is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Lactation
UNSAFE
Torsirin 100 mg/5ml Injection is unsafe to use during lactation. Data suggests that the drug may cause toxicity to the baby, or the mother is suffering from a condition in which breastfeeding is not advisable.
Driving
Torsirin 100 mg/5ml Injection may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Kidney
Torsirin 100 mg/5ml Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Torsirin 100 mg/5ml Injection may not be needed in these patients. Please consult your doctor.
Use of this medicine is not recommended for patients on dialysis.
Liver
There is limited information available on the use of Torsirin 100 mg/5ml Injection in patients with liver disease. Please consult your doctor.

What if you miss a dose of Torsirin Injection?

If you miss a dose of Torsirin 100 mg/5ml Injection, please consult your doctor.

Alternate Brands

For informational purposes only. Consult a doctor before taking any medicines.
Torsirin 100 mg/5ml Injection
ReliTecan 100mg Injection
Reliance Life Sciences
₹1400/Injection
save 56%

Expert Advice

  • Torsirin 100 mg/5ml Injection is used in combination with other medicines for the treatment of metastatic cancer of the colon and rectum.
  • It is given via a drip into a vein (intravenous infusion).
  • It may cause dizziness and visual disturbances. Do not drive or do anything that requires mental focus until you know how it affects you.
  • Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine.
  • Your doctor may get regular blood tests done to monitor your blood cells, kidney and liver function during treatment with this medicine.
  • Inform your doctor immediately if you notice any signs of infection such as fever, sore throat or rash.
  • Inform your doctor if you notice passage of blood in stools or experience dizziness or faintness, continuous episodes of nausea, vomiting, diarrhea or fever.

Patient Concerns

Questions Related to Torsirin

arrow
Very high fever up to 104f with cough and cold.medicine given Taxim o DT 100mg 1?2 P- 250 mg syrup 5ml ?2 Altime cf junior syrup 5ml ? 2time .no improvement
Dr. Gopal Samdani
Child Specialist
you can give P 250 every 6hrlyRevisit to your consultant or take 2nd opinion. Some times investigations are required to make diagnosis
Is ulcers curable G2 stage of cancer in rectum area
Dr. Pawan Rawal
Gastroenterologist
Needs evaluation Please meet a Gastro surgeon
arrow
Do you have any questions related to Torsirin 100 mg/5ml Injection?

Related Products

Related Lab Tests
Disclaimer: 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover all possible side effects, drug interactions or warnings or alerts. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
References
  1. Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 951.
  2. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 736-37.
  3. Irinotecan hydrochloride trihydrate. Sandwich, Kent: Pfizer Limited; 1995 [revised May 2018]. Accessed 26 Jan. 2019] (online) Available from:External Link
  4. U.S. National Library of Medicine. Irinotecan. [Accessed 26 Mar. 2019] (online) Available from:External Link
  5. Central Drugs Standard Control Organisation (CDSCO). [Accessed 26 Mar. 2019] (online) Available from:External Link
  6. Irinotecan. Barnstaple, Devon: Accord-UK Ltd; 2007 [revised 6 Aug. 2018]. [Accessed 26 Mar. 2019] (online) Available from:External Link
Manufacturer/Marketer Address
213, Shivai Dongre Industrial Premises, Andheri - Kurla Road, Andheri(E), Mumbai - 400 072, Maharashtra, India.
MRP
3200
1 Injection in 1 vial
SOLD OUT